<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How does Soleno's expense ratio compare to peers?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 11:28pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Soleno Therapeutics, Inc. (SLNO) has an expense ratio that is not available. However, we can compare the expense ratios of Soleno's peers, which are as follows:


|code|Ticker|Name|market_code|
|---|---|---|---|
|INSP|INSP.N|Inspire Medical|169|
|SOLV|SOLV.N|Solventum|169|
|SNN|SNN.N|Smith &amp; Nephew|169|
|IRTC|IRTC.O|iRhythm Technologies|185|
|GKOS|GKOS.N|Glaukos|169|
|BLCO|BLCO.N|Bausch + Lomb|169|
|TMDX|TMDX.O|TransMedics Group|185|
|NVST|NVST.N|Envista Holdings|169|
|SLNO|SLNO.O|Soleno Therapeutics|186|
|ENOV|ENOV.N|Enovis|169|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax){return {layout:"default",data:[{noData:c,currentQuestion:h,textDescription:Q,comeFrom:"AInvestShareLink",events:[],answerSource:q}],fetch:{},error:r,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:R,agent_id:a,output_media_info:[],task_id:a,language:a,source:q,cache_builder:a,reply_action:"Answer",execute_mode:C,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How does Soleno's expense ratio compare to peers?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How does Soleno's expense ratio compare to peers?\",\"user_id\":\"dp66186865\",\"user_name\":\"\",\"trace_id\":\"df29a78b-dcb5-4e94-aba6-8c5b7db722d4\",\"session_id\":\"df29a78b-dcb5-4e94-aba6-8c5b7db722d4\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:l,text:"2 results found:\n|stock code|stock name|Payout Ratio[20250331]|\n|---|---|---|\n|SNN|Smith & Nephew|35.18%|\n|STVN|Stevanato Group|1.76%|\n",query_data:{number:S,title:D,query_type:l,condition:a,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:c,data_add:U,add_index:e}}}],answer_chain_name:V,agent_mode:W,native_answer:a,come_from:a,text_answer:Q,trace_id:j,cost:35753,event_names:a,question:h,fallback_type:X,input_type:Y,fall_back_reason:{fall_back_type:X,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:j,first_return_cost:2858,cache_type:"no_cache",question_id:j,transfer_question:h,signal_type:"ON_COMPLETE",start_time:E,remote_svc:q,slots:[],answer_type:C,user_id:x,skill_name:F},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:x,question:h,source:q,raw_question:h,version:"3.4.1",action_name:F,nlu:{entity:[{type:Z,value:_,market:G}]},output_time:E,deep_research:c,deep_thinking:c,agent_mode:W},extra:{}},{answer_path:m,section:{id:n,info_texts:["Thinking"],show_type:o,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:m,section:{id:n,info_texts:["Querying ETF: SLNO's Peer ETFs"],show_type:o,choice:[],result_page:{},tag_info_list:[],is_last:b,status:H},logs:[],extra:{action:$,action_input:"SLNO's Peer ETFs",thought:"The user wants to compare Soleno's expense ratio with its peers. I should focus on identifying key competitors and gathering relevant data. I will use ETFQuery to identify potential competitors. Then, I will use ETFQuery for Soleno and identified stocks' expense ratio."}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:m,section:{id:n,info_texts:["Searching Web: Soleno Therapeutics' peers"],show_type:o,choice:[],result_page:{},tag_info_list:[],is_last:b,status:H},logs:[],extra:{action:"Searching Web",action_input:"Soleno Therapeutics' peers",thought:"I was unable to obtain Soleno's peers using ETFQuery, now I will try again using Search."}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:m,section:{id:n,info_texts:["Querying ETF: SLNO, SNN, PEN, SOLV, STVN, GKOS, BLCO, INSP, IRTC, NVST, TMDX, ENOV Expense Ratio"],show_type:o,choice:[],result_page:{},tag_info_list:[],is_last:b,status:H},logs:[],extra:{action:$,action_input:D,thought:"I have obtained that Soleno Therapeutics' peers include Smith & Nephew, Penumbra, Solventum, Stevanato Group, Glaukos, Bausch + Lomb, Inspire Medical Systems, Inari Medical, PROCEPT BioRobotics, iRhythm Technologies, Envista, TransMedics Group, and Enovis. Since comparison is needed, Now I will use ETFQuery to obtain the expense ratio of Soleno and these peers together."}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:m,section:{id:n,info_texts:["Generating Answer"],show_type:o,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:y,voice_txt:"Sol",text_answer:aa,rich_text:aa,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:y,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:D,query_type:l,trace_data:a,index:S,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:c,data_add:U,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:y,voice_txt:":\n\n",text_answer:ab,rich_text:ab,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:ac,market_id:G,name:I,domain:Z},pos:e,section_id:s,txt:I,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:ad,choice:[],result_page:{components:[{uuid:"ddc8a8dc6226fc5c",config:{score:R,show_type:ae,scoreRuleNames:a,show_type_id:901,title:"表格",render:{merge:{Name:{keys:[t],title:z}},exclude:[t,J,A]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:af,h2:a},show_type:K}},data:{chunks_info:"[]",code_count:L,columns:[{index_name:t,key:t,label:"hq_code",source:M,type:f},{domain:ag,feKey:A,index_name:A,key:A,label:t,origin_index:"stock code",source:M,type:f,unit:a},{domain:ag,feKey:z,index_name:z,key:z,label:"name",origin_index:"stock name",source:M,type:f,unit:a},{index_name:J,key:J,type:f}],condition:"[{\"sonSize\":1,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL INSP.N\\u003e-\\u003cSTVN.N\\u003e-\\u003cSNN.N\\u003e-\\u003cIRTC.O\\u003e-\\u003cNVST.N\\u003e-\\u003cGKOS.N\\u003e-\\u003cBLCO.N\\u003e-\\u003cSOLV.N\\u003e-\\u003cTMDX.O\\u003e-\\u003cENOV.N\\u003e-\\u003cPEN.N\\u003e-\\u003cSLNO.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"INSP.N\\u003e-\\u003cSTVN.N\\u003e-\\u003cSNN.N\\u003e-\\u003cIRTC.O\\u003e-\\u003cNVST.N\\u003e-\\u003cGKOS.N\\u003e-\\u003cBLCO.N\\u003e-\\u003cSOLV.N\\u003e-\\u003cTMDX.O\\u003e-\\u003cENOV.N\\u003e-\\u003cPEN.N\\u003e-\\u003cSLNO.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:L,datas:[{code:"INSP",Ticker:"INSP.N",market_code:g,Name:"Inspire Medical"},{code:"SOLV",Ticker:"SOLV.N",market_code:g,Name:"Solventum"},{code:"SNN",Ticker:"SNN.N",market_code:g,Name:"Smith & Nephew"},{code:"IRTC",Ticker:"IRTC.O",market_code:ah,Name:"iRhythm Technologies"},{code:"GKOS",Ticker:"GKOS.N",market_code:g,Name:"Glaukos"},{code:"BLCO",Ticker:"BLCO.N",market_code:g,Name:"Bausch + Lomb"},{code:"TMDX",Ticker:"TMDX.O",market_code:ah,Name:"TransMedics Group"},{code:"NVST",Ticker:"NVST.N",market_code:g,Name:"Envista Holdings"},{code:ac,Ticker:_,market_code:G,Name:I},{code:"ENOV",Ticker:"ENOV.N",market_code:g,Name:"Enovis"},{code:"STVN",Ticker:"STVN.N",market_code:g,Name:"Stevanato Group"},{code:"PEN",Ticker:"PEN.N",market_code:g,Name:"Penumbra"}],meta:{extra:{}},row_count:L,status_code:e,status_msg:"ok"},category:"generic",chart_type:a,show_type:ae,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:af,h2:a},show_type:K},support_refresh:b,data_config:{query:a,query_type:l,data_ext_params:{}}}],global:{query_type:l},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"tableV1\",\"uuid\":\"ddc8a8dc6226fc5c\"}]"},render_for:N},data_config:{query:a,query_type:l,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"80ec9549-4db5-410f-ba7a-3e076db2afd7"},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:y,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:m,section:{id:n,info_texts:["Completed"],show_type:o,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ad,choice:[{display_text:u,query_text:u,trace_info:{item_id:"a0633b2537d3ee82930b402367559326",item_type:p,item_name:u,rec_info:ai}},{display_text:v,query_text:v,trace_info:{item_id:"53b9dbb3152f090202a49327050679c3",item_type:p,item_name:v,rec_info:aj}},{display_text:w,query_text:w,trace_info:{item_id:"0f2b118ba516ddbb53715d40f548cec8",item_type:p,item_name:w,rec_info:ak}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:K,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:al,related_name:am}],puuid:O,tag:a,category:"custom",uuid:an}],global:{urp_static_data:[{name:am,value:{status_code:e,columns:[{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar},{type:f,index_name:as,key:as}],datas:[{send_text:u,item_type:p,rec_info:ai,display_text:u,rec_reason:a},{send_text:v,item_type:p,rec_info:aj,display_text:v,rec_reason:a},{send_text:w,item_type:p,rec_info:ak,display_text:w,rec_reason:a}],dataSize:al,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:at,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:B,"min-height":"100%",position:au,height:B},isMaterial:c,id:at,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:P,componentUuid:an,script:[{name:av,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:P,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:P},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:B,position:au,height:B},isMaterial:b,_id:19,id:av,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:N,voice_txt:a,tracking_info:{},uuid:O},order:{is_auto:c,render_for:N,chart_type:"command",puuid:O}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:F,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:C,answer_chain_name:V},is_deep_research:c,deep_thinking:c,create_time:1746718138808},is_last:b}],questionItem:{data:{qStr:h,encodeFlag:c,imageData:r,docsData:[],quoteData:r},tplType:"question"},events:aw,agentId:a,param:{entity_info:{},add_info:{ori_question:h},event_list:aw,client_ip:a,question:h,user_id:x,user_name:a,trace_id:j,session_id:j,source:q,input_type:Y}}],userId:x,userName:a,startTime:E,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:r,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:r,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-does-solenos-expense-ratio-compare-to-peers-68ee75\u002F",config:{_app:{basePath:ax,assetsPath:ax,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","169","How does Soleno's expense ratio compare to peers?","signal","df29a78b-dcb5-4e94-aba6-8c5b7db722d4",999,"intusstock","progress\u002Fsearching_for",1000,"searching_for","llm_generated","ths_ainvest_lite_web",null,2001,"code","🎢 What is Soleno's current expense ratio?","🔍 How do analysts rate Soleno's expense management?","💼 How does Soleno's expense ratio affect its profitability?","dp66186865","rich_text","Name","Ticker","auto","agent","SLNO, SNN, PEN, SOLV, STVN, GKOS, BLCO, INSP, IRTC, NVST, TMDX, ENOV Expense Ratio",1746718103056,"review stocks","186","thinking","Soleno Therapeutics","market_code","title1",12,"fixed_index","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Soleno Therapeutics, Inc. (SLNO) has an expense ratio that is not available. However, we can compare the expense ratios of Soleno's peers, which are as follows:\n\n\n|code|Ticker|Name|market_code|\n|---|---|---|---|\n|INSP|INSP.N|Inspire Medical|169|\n|SOLV|SOLV.N|Solventum|169|\n|SNN|SNN.N|Smith & Nephew|169|\n|IRTC|IRTC.O|iRhythm Technologies|185|\n|GKOS|GKOS.N|Glaukos|169|\n|BLCO|BLCO.N|Bausch + Lomb|169|\n|TMDX|TMDX.O|TransMedics Group|185|\n|NVST|NVST.N|Envista Holdings|169|\n|SLNO|SLNO.O|Soleno Therapeutics|186|\n|ENOV|ENOV.N|Enovis|169|\n\n",1,7,"select   stock_code,   payout_ratio from   ustock_fin_data where   stock_code in (     'SLNO.O',     'SNN.N',     'PEN.N',     'SOLV.N',     'STVN.N',     'GKOS.N',     'BLCO.N',     'INSP.N',     'IRTC.O',     'NVST.N',     'TMDX.O',     'ENOV.N'   )",-1,"agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","SLNO.O","Querying ETF","Soleno Therapeutics, Inc. (SLNO) has an expense ratio that is not available. However, we can compare the expense ratios of Soleno's peers, which are as follows[^7]",":\n\n\n``` visual\n{\"uuid\":\"80ec9549-4db5-410f-ba7a-3e076db2afd7\"}\n```","SLNO","result_page","tableV1","INSP, SOLV, SNN, IRTC, GKOS...","abs_国际美股领域","185","2+679_496_21_554+0+0+df29a78b-dcb5-4e94-aba6-8c5b7db722d4+a0633b2537d3ee82930b402367559326+llm_generated+aimeTagAnalysis+0+0.01407050434499979+1","2+679_496_21_554+0+0+df29a78b-dcb5-4e94-aba6-8c5b7db722d4+53b9dbb3152f090202a49327050679c3+llm_generated+aimeTagAnalysis+0+0.0087613919749856+2","2+679_496_21_554+0+0+df29a78b-dcb5-4e94-aba6-8c5b7db722d4+0f2b118ba516ddbb53715d40f548cec8+llm_generated+aimeTagAnalysis+0+0.008173861540853977+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>